Cargando…

Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial

BACKGROUND: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and prefer...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoepke, Christopher E., Chaussee, Erin L., Matlock, Daniel D., Thompson, Jocelyn S., McIlvennan, Colleen K., Ambardekar, Amrut V., Schaffer, Elisabeth M., Khazanie, Prateeti, Scherer, Laura, Arnold, Robert M., Allen, Larry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783927/
https://www.ncbi.nlm.nih.gov/pubmed/34296623
http://dx.doi.org/10.1177/0272989X211028234
_version_ 1784638639256371200
author Knoepke, Christopher E.
Chaussee, Erin L.
Matlock, Daniel D.
Thompson, Jocelyn S.
McIlvennan, Colleen K.
Ambardekar, Amrut V.
Schaffer, Elisabeth M.
Khazanie, Prateeti
Scherer, Laura
Arnold, Robert M.
Allen, Larry A.
author_facet Knoepke, Christopher E.
Chaussee, Erin L.
Matlock, Daniel D.
Thompson, Jocelyn S.
McIlvennan, Colleen K.
Ambardekar, Amrut V.
Schaffer, Elisabeth M.
Khazanie, Prateeti
Scherer, Laura
Arnold, Robert M.
Allen, Larry A.
author_sort Knoepke, Christopher E.
collection PubMed
description BACKGROUND: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and preferences for left ventricular assist devices (LVADs) for advanced heart failure. METHODS AND RESULTS: We conducted a secondary analysis of patients undergoing LVAD evaluation at 6 US centers. Surveys at baseline, 1 month, and 6 months included a single 10-point scale on the value of aggressive care (score 1 = “do everything,” 10 = “live with whatever time I have left”) and treatment preference (LVAD, unsure, no LVAD). Data were captured for 232 patients, of whom 196 were ultimately deemed medically eligible for LVAD, and 161 were surgically implanted by 1 month. Values at baseline favored aggressive care (mean [SD], 2.49 [2.63]), trending toward less aggressive over time (1 month, 2.63 [2.05]; 6 months, 3.22 [2.70]). Between baseline and 1 month, values scores changed by ≥2 points in 28% (50/176), as did treatment preferences for 18% (29/161) of patients. Values score changes over time were associated with lower illness acceptance, depression, and eventual LVAD ineligibility. Treatment preference change was associated with values score change. CONCLUSION: Most patients considering LVAD were stable in their values and treatment preferences. This stability, as well as the association between unstable treatment preferences and changes to stated values, highlighted the clinical utility of the values scale of aggressiveness. However, a substantial minority reported significant changes over time that may complicate the process of shared decision making. Improved methods to elicit and clarify values, including support to those with depression and low illness acceptance, is critical for patient-centered care.
format Online
Article
Text
id pubmed-8783927
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87839272022-03-15 Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial Knoepke, Christopher E. Chaussee, Erin L. Matlock, Daniel D. Thompson, Jocelyn S. McIlvennan, Colleen K. Ambardekar, Amrut V. Schaffer, Elisabeth M. Khazanie, Prateeti Scherer, Laura Arnold, Robert M. Allen, Larry A. Med Decis Making Original Research Articles BACKGROUND: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and preferences for left ventricular assist devices (LVADs) for advanced heart failure. METHODS AND RESULTS: We conducted a secondary analysis of patients undergoing LVAD evaluation at 6 US centers. Surveys at baseline, 1 month, and 6 months included a single 10-point scale on the value of aggressive care (score 1 = “do everything,” 10 = “live with whatever time I have left”) and treatment preference (LVAD, unsure, no LVAD). Data were captured for 232 patients, of whom 196 were ultimately deemed medically eligible for LVAD, and 161 were surgically implanted by 1 month. Values at baseline favored aggressive care (mean [SD], 2.49 [2.63]), trending toward less aggressive over time (1 month, 2.63 [2.05]; 6 months, 3.22 [2.70]). Between baseline and 1 month, values scores changed by ≥2 points in 28% (50/176), as did treatment preferences for 18% (29/161) of patients. Values score changes over time were associated with lower illness acceptance, depression, and eventual LVAD ineligibility. Treatment preference change was associated with values score change. CONCLUSION: Most patients considering LVAD were stable in their values and treatment preferences. This stability, as well as the association between unstable treatment preferences and changes to stated values, highlighted the clinical utility of the values scale of aggressiveness. However, a substantial minority reported significant changes over time that may complicate the process of shared decision making. Improved methods to elicit and clarify values, including support to those with depression and low illness acceptance, is critical for patient-centered care. SAGE Publications 2021-07-23 2022-04 /pmc/articles/PMC8783927/ /pubmed/34296623 http://dx.doi.org/10.1177/0272989X211028234 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Articles
Knoepke, Christopher E.
Chaussee, Erin L.
Matlock, Daniel D.
Thompson, Jocelyn S.
McIlvennan, Colleen K.
Ambardekar, Amrut V.
Schaffer, Elisabeth M.
Khazanie, Prateeti
Scherer, Laura
Arnold, Robert M.
Allen, Larry A.
Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
title Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
title_full Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
title_fullStr Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
title_full_unstemmed Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
title_short Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
title_sort changes over time in patient stated values and treatment preferences regarding aggressive therapies: insights from the decide-lvad trial
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783927/
https://www.ncbi.nlm.nih.gov/pubmed/34296623
http://dx.doi.org/10.1177/0272989X211028234
work_keys_str_mv AT knoepkechristophere changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT chausseeerinl changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT matlockdanield changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT thompsonjocelyns changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT mcilvennancolleenk changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT ambardekaramrutv changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT schafferelisabethm changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT khazanieprateeti changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT schererlaura changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT arnoldrobertm changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial
AT allenlarrya changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial